PT1200129E - Máscara de sabor para preparações orais líquidas de quinolona com utilização de resinas de permuta iónica - Google Patents
Máscara de sabor para preparações orais líquidas de quinolona com utilização de resinas de permuta iónica Download PDFInfo
- Publication number
- PT1200129E PT1200129E PT00945340T PT00945340T PT1200129E PT 1200129 E PT1200129 E PT 1200129E PT 00945340 T PT00945340 T PT 00945340T PT 00945340 T PT00945340 T PT 00945340T PT 1200129 E PT1200129 E PT 1200129E
- Authority
- PT
- Portugal
- Prior art keywords
- ion exchange
- exchange resins
- liquid preparations
- taste masking
- quinolone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35354999A | 1999-07-14 | 1999-07-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1200129E true PT1200129E (pt) | 2008-12-17 |
Family
ID=23389610
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT00945340T PT1200129E (pt) | 1999-07-14 | 2000-07-12 | Máscara de sabor para preparações orais líquidas de quinolona com utilização de resinas de permuta iónica |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1200129B1 (pt) |
| JP (2) | JP2003504416A (pt) |
| AR (1) | AR024715A1 (pt) |
| AT (1) | ATE411047T1 (pt) |
| AU (1) | AU777993B2 (pt) |
| BG (1) | BG65656B1 (pt) |
| BR (1) | BR0012439A (pt) |
| CA (1) | CA2378894C (pt) |
| CY (1) | CY1108801T1 (pt) |
| CZ (1) | CZ302919B6 (pt) |
| DE (1) | DE60040540D1 (pt) |
| DK (1) | DK1200129T3 (pt) |
| ES (1) | ES2313897T3 (pt) |
| HU (1) | HUP0202229A3 (pt) |
| IL (2) | IL147242A0 (pt) |
| MX (1) | MXPA02000501A (pt) |
| NO (1) | NO20020134D0 (pt) |
| NZ (1) | NZ516536A (pt) |
| PL (1) | PL202027B1 (pt) |
| PT (1) | PT1200129E (pt) |
| SI (1) | SI1200129T1 (pt) |
| SK (1) | SK287415B6 (pt) |
| WO (1) | WO2001005431A1 (pt) |
| ZA (1) | ZA200200026B (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6589955B2 (en) | 2001-06-20 | 2003-07-08 | Bristol-Myers Squibb Company | Pediatric formulation of gatifloxacin |
| DE10224086A1 (de) * | 2002-05-31 | 2003-12-11 | Bayer Ag | Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker |
| JP5009707B2 (ja) * | 2007-07-10 | 2012-08-22 | 東和薬品株式会社 | 不快な味がマスキングされたキノロン系抗菌剤の経口投与用液剤 |
| HUE029400T2 (en) * | 2010-05-19 | 2017-03-28 | Astellas Pharma Inc | Pharmaceutical composition containing Solifenacin |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4788055A (en) * | 1985-12-09 | 1988-11-29 | Ciba-Geigy Corporation | Resinate sustained release dextromethorphan composition |
| US4808411A (en) * | 1987-06-05 | 1989-02-28 | Abbott Laboratories | Antibiotic-polymer compositions |
| DE3719764A1 (de) * | 1987-06-13 | 1988-12-22 | Bayer Ag | Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung |
| IL90245A (en) * | 1988-05-11 | 1994-04-12 | Glaxo Group Ltd | Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it |
| US4996047A (en) * | 1988-11-02 | 1991-02-26 | Richardson-Vicks, Inc. | Sustained release drug-resin complexes |
| US5275820A (en) * | 1990-12-27 | 1994-01-04 | Allergan, Inc. | Stable suspension formulations of bioerodible polymer matrix microparticles incorporating drug loaded ion exchange resin particles |
| DE69224071T2 (de) * | 1991-09-17 | 1998-05-07 | Alcon Lab Inc | Chinolan-antibiotika und polystyrolsulfonat enthaltende zusammensetzungen |
| JPH0710747A (ja) * | 1993-04-28 | 1995-01-13 | Takeda Chem Ind Ltd | 固形製剤およびその製造方法 |
| EP0622083B1 (en) * | 1993-04-28 | 1999-06-30 | Takeda Chemical Industries, Ltd. | Taste masked solid preparation and its production |
| JP2000103730A (ja) * | 1998-07-31 | 2000-04-11 | Otsuka Pharmaceut Co Ltd | 服用感が改善された医薬組成物 |
-
2000
- 2000-07-12 AT AT00945340T patent/ATE411047T1/de active
- 2000-07-12 NZ NZ516536A patent/NZ516536A/en not_active IP Right Cessation
- 2000-07-12 SI SI200031014T patent/SI1200129T1/sl unknown
- 2000-07-12 ES ES00945340T patent/ES2313897T3/es not_active Expired - Lifetime
- 2000-07-12 WO PCT/US2000/018948 patent/WO2001005431A1/en active IP Right Grant
- 2000-07-12 MX MXPA02000501A patent/MXPA02000501A/es active IP Right Grant
- 2000-07-12 SK SK53-2002A patent/SK287415B6/sk not_active IP Right Cessation
- 2000-07-12 PL PL352183A patent/PL202027B1/pl not_active IP Right Cessation
- 2000-07-12 HU HU0202229A patent/HUP0202229A3/hu not_active Application Discontinuation
- 2000-07-12 AU AU59302/00A patent/AU777993B2/en not_active Ceased
- 2000-07-12 DK DK00945340T patent/DK1200129T3/da active
- 2000-07-12 DE DE60040540T patent/DE60040540D1/de not_active Expired - Lifetime
- 2000-07-12 BR BR0012439-7A patent/BR0012439A/pt not_active Application Discontinuation
- 2000-07-12 CA CA002378894A patent/CA2378894C/en not_active Expired - Lifetime
- 2000-07-12 PT PT00945340T patent/PT1200129E/pt unknown
- 2000-07-12 IL IL14724200A patent/IL147242A0/xx unknown
- 2000-07-12 CZ CZ20020071A patent/CZ302919B6/cs not_active IP Right Cessation
- 2000-07-12 EP EP00945340A patent/EP1200129B1/en not_active Expired - Lifetime
- 2000-07-12 JP JP2001510519A patent/JP2003504416A/ja active Pending
- 2000-07-27 AR ARP000103565A patent/AR024715A1/es active IP Right Grant
-
2001
- 2001-12-23 IL IL147242A patent/IL147242A/en not_active IP Right Cessation
-
2002
- 2002-01-02 ZA ZA200200026A patent/ZA200200026B/en unknown
- 2002-01-11 NO NO20020134A patent/NO20020134D0/no unknown
- 2002-01-21 BG BG106329A patent/BG65656B1/bg unknown
-
2008
- 2008-12-31 CY CY20081101520T patent/CY1108801T1/el unknown
-
2011
- 2011-09-12 JP JP2011198876A patent/JP2011246497A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| SK532002A3 (en) | 2002-05-09 |
| SK287415B6 (sk) | 2010-09-07 |
| BG65656B1 (bg) | 2009-05-29 |
| ZA200200026B (en) | 2003-04-02 |
| BR0012439A (pt) | 2002-04-02 |
| WO2001005431A1 (en) | 2001-01-25 |
| IL147242A (en) | 2008-12-29 |
| NO20020134L (no) | 2002-01-11 |
| ES2313897T3 (es) | 2009-03-16 |
| AR024715A1 (es) | 2002-10-23 |
| HUP0202229A2 (hu) | 2002-11-28 |
| NZ516536A (en) | 2003-09-26 |
| NO20020134D0 (no) | 2002-01-11 |
| IL147242A0 (en) | 2002-08-14 |
| CA2378894C (en) | 2005-11-22 |
| PL352183A1 (en) | 2003-08-11 |
| EP1200129B1 (en) | 2008-10-15 |
| AU777993B2 (en) | 2004-11-11 |
| JP2011246497A (ja) | 2011-12-08 |
| AU5930200A (en) | 2001-02-05 |
| JP2003504416A (ja) | 2003-02-04 |
| ATE411047T1 (de) | 2008-10-15 |
| HUP0202229A3 (en) | 2008-10-28 |
| DE60040540D1 (de) | 2008-11-27 |
| CA2378894A1 (en) | 2001-01-25 |
| CY1108801T1 (el) | 2012-05-23 |
| SI1200129T1 (sl) | 2009-06-30 |
| BG106329A (en) | 2002-08-30 |
| MXPA02000501A (es) | 2002-07-02 |
| CZ302919B6 (cs) | 2012-01-18 |
| CZ200271A3 (cs) | 2002-04-17 |
| DK1200129T3 (da) | 2009-01-12 |
| EP1200129A1 (en) | 2002-05-02 |
| PL202027B1 (pl) | 2009-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CZ20011518A3 (cs) | Farmaceutický prostředek | |
| HUP0201765A3 (en) | Taste masked pharmaceutical liquid formulations | |
| IL142642A0 (en) | Pharmaceutical moxifloxacin preparation | |
| AU5279800A (en) | Ion exchange resins and methods of making the same | |
| IL148379A0 (en) | Pharmaceutical solutions of levosimendan | |
| AU2001269291A1 (en) | Therapeutic acridone and acridine compounds | |
| HK1041827B (zh) | 用於治療雌激素依賴性疾病的化合物以及製備和使用上述化合物的方法 | |
| EG22530A (en) | Preparation of substituted piperidin-4-ones | |
| IL147242A0 (en) | Taste masking of oral quinolone liquid preparations using ion exchange resins | |
| HUP0201667A3 (en) | Oral form of administration | |
| ZA200400269B (en) | Pharmaceutical preparations containing ion exchange resins charged with fluoro-quinolone | |
| IL149534A0 (en) | Preparation of 3-substituted-4-arylquinolin-2-one derivatives | |
| AU2002345086A1 (en) | Pharmaceutical preparations containing ion exchange resins charged with fluoroquinolone | |
| IL147410A0 (en) | L-acetylcarnitine and l-propionylcarnitine containing composition for the prevention and treatment of kidney dysfunctions and diseases | |
| EP1142589A4 (en) | MEDICAL COMPOSITIONS | |
| GB9912167D0 (en) | Antiperspirant salts and methods of their preparation | |
| EP1201245A4 (en) | FUNCTIONAL ORAL PREPARATIONS | |
| AU7563100A (en) | Method of preparation of sildenafil | |
| GB0030028D0 (en) | Preparation of triarylamines | |
| SI1194153T1 (en) | Taste masked pharmaceutical liquid formulations | |
| AUPQ030599A0 (en) | Magnetic treatment of fluids | |
| GB9930266D0 (en) | Oral administration of beneficial substances | |
| AUPP728998A0 (en) | Therapeutic compounds and methods for their preparation | |
| GB9810260D0 (en) | Novel use of quinine | |
| GB9918272D0 (en) | Administration of beneficial substances |